Skip to content

Fast-track surgery in hepatocellular carcinoma following open liver resection: a prospective randomized controlled trial

Fast-track surgery in hepatocellular carcinoma following open liver resection: a prospective randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004946
Enrollment
Unknown
Registered
2014-06-28
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver surgery

Interventions

A:fast-track surgery with the multimodal analgesia and the reasonable incision
B:common treatment following open liver resection

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18 to 65 years old; 2. clinical diagnosed primary hepatocellular carcinoma; 3. open liver resection for surgery; 4. ChildePugh Class A liverfunctional status; 5. organ with enough function; 6. voluntary surgical treatment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. age younger than 18 and older than 65 years old; 2. Patients with other primary malignant tumors; 3. patients with benign lesions or metastatic tumors in liver; 4. upper abdominal surgery; 5. resection with other organ; 6. patients with American Society of Anesthesiologists physical status (ASA) 4-5; 7. serious mental illness; 8. have unstable angina or myocardial infarction within six months; 9. sustained systemic glucocorticoid treatment history within 1 month; 10. Patients who are unable or unwilling to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
postoperative length of stay (LOS);

Secondary

MeasureTime frame
postoperative complications;mortality within 30 days of surgery;Readmission rate;recovery of bowel function(passage of flatus and stools);hospital cost;index of surgical stress response;VAS score after surgery;measurement of quality of life instruments for cancer patients;

Countries

China

Contacts

Public ContactWen Tianfu
SCTianfuwen@hotmail.com+86 18980601471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026